Emcure Pharmaceuticals conducted a postal ballot for appointing C S Muralidharan as an Independent Director.
Remote e-voting was open from March 26 to April 24, 2026, with scrutinizer overseeing the process.
The resolution was passed with requisite majority as confirmed by the scrutinizer's report.